One of the first studies on JCS at scene of injury and mortality. Although JCS at scene may not differ significantly from JCS at emergency department presentation, earlier triage is known to improve outcomes across the trauma literature.
Strengths: large sample size, straightforward study design with clear message and appropriate applicability in emergency clinical settings. This is a clear and well-written paper.
I offer the following suggestions: 1) Discussion of potential pitfalls of assessment using the JCS. While it evaluates eye opening, it relies on understanding of the pathological processes that may affect eye opening spontaneously, to voice, and to central pain. Lack of response to central noxious stim usually implies a severe central process depressing consciousness, but this is not always recognized nor assessed appropriately. Unconsciousness can also be due to systemic insults, electrolyte abnormalities, intoxication, baseline psychiatric comorbidities, and others. As the GCS can be incorrectly administered or scored (e.g. in the setting of intoxication or a sleeping patient), the JCS likely has the same caveats and nuances of administration. This is an relevant point in the context of the important findings of this paper, and would improve the applicability of these findings to the clinical audience.
2) The JCS has increased tiers of scoring with up to 9 tiers of scoring (not including the "alert") patient. are there plans to analyze the prognostic and diagnostic ability of more granular tiers of JCS?
3) Mortality from trauma can be due to a wide range of pathologies, primary and secondary injuries. Recommend authors discuss this in setting of using JCS uniformly across all trauma indications in the manuscript. 4) How do the authors interpret the lower c-statistic for AIS>=3 and ISS>=16? The AIS and ISS are not very specific for severe head injury and polytrauma respectively. Are there plans to analyze JCS with radiographic evidence of TBI and/or AIS threshold in multiple organ systems (e.g. AIS >=2 in multiple body systems) respectively? Not necessarily required for the purposes of the current manuscript, but should be mentioned in the Discussion or Limitations. 2004 -2017 ? probably due to data acquisition limits, but should be described briefly in Methods
5) Why years

GENERAL COMMENTS
Thank you for the opportunity to review this article investigating the performance of Japan Coma Scale from the Japan Trauma Data Bank. 164,723 patients were included in this study, and the overall mortality was 10.9%. The authors reported a strong association of higher JCS level with inhospital mortality and the c-statistics of 0.845, and concluded that JCS is useful for field triage of trauma victims. The study objective and the analysis are explicit and well conducted. However, the result needs to be presented more clearly, along with a more detailed discussion of the findings.
-A recent systematic review on tGCS, mGCS and Simplified Motor Scale [ref 3 from the authors' list] reported pooled AUROC of 0.877-0.884 (tGCS), 0.855 (mGCS) and 0.840 (Simplified Motor Scale) for in-hospital mortality. Although the current study did not compare the results of JCS and other coma scales, the authors should discuss the performance of JCS compared to the previously published results in the paper. The discussion section needs to be expanded.
-Low conscious level in trauma patients maybe due to traumatic brain injury, anoxic brain injury and haemorrhagic shock. The association of a coma scale with the primary outcome (mortality) and secondary outcomes (coma on arrival, head AIS 3 or above, ISS 16 or above) will depend on many factors including the quality of the patient treatment, transportation time, availability of head CT scan, the proportion of TBI to those with haemorrhagic shock etc. The authors should provide more background information related to the study participants in Japan, and some information about how the JCS results (any pre-hospital protocols etc) that may affect the clinical management of these patients. This is important for international readers not familiar with the Japanese trauma system. (see later comments regarding Table 2 ).
-The choice of the secondary outcome of "ISS 16 or above" warrants further elaboration. Other secondary outcomes that can be considered includes whether neurosurgical intervention/ intubation was required.
Introduction/ methods -It is currently difficult to understand the meaning of level 0 in JCS: P3 line 41: Additionally, although the originally published JCS did not include a state of alertness, this has been described conventionally as "Level 0" and is generally reported together with Level 1.
P5 line 14: As noted in the Introduction, alertness was recorded as a JCS score of "0" in the JTDB; these patients were combined with JCS Level 1 patients -the exclusion criteria of missing data and the inclusion of this group for sensitivity analysis is confusing P4 line 55: Moreover, we also excluded patients for whom information about the JCS in pre-hospital settings and inhospital mortality were unavailable. P6 line 3: Additionally, we performed a sensitivity analysis to demonstrate the robustness of the primary outcome results and compensate for the risk of selection bias due to the missing JCS and mortality data.
-suggest to change "severe patient condition" to high JCS level or similar P6 line 8: 2, missing because of a severe patient condition and death or a minor injury and survival;
Results: -Missing data (excluded from main analysis) comprised of 17% of all eligible patients (from Figure 1) , what was the percentage of missing data for secondary outcomes?
-This sentence needs to be rewritten with numbers provided. P6 line 48: For the distribution between JCS at the scene and GCS upon arrival at hospital, almost all JCS Level 1 patients had a GCS of 14-15 upon arrival at the hospital, while most JCS Level 3 patients had a GCS ≤8 (Supplementary file).
-The Diagnostic ability section, confidence interval needs to be provided for c-statistics results -Main findings of secondary outcomes should be described in the results section.
-Authors should provide some description of the findings, or at least list what other parameters were used P7 line 10: The adjusted OR of the other parameters were described in another part (Supplementary file).
-Again for sensitivity analysis, summary of results should be provided in the manuscript. So that readers do not need to go to the supplementary files to know the results. Tables  -Table 2 : Sex, age, type of injury, RR, SBP was provided. The descriptive statistics of the primary and secondary outcomes should be included.
-Other information like the intubation rates, neurosurgical intervention rates, ICU admission, hospital length of stay and the prehospital transportation time will help the readers to better understand the trauma study participants in japan. One of the first studies on JCS at scene of injury and mortality. Although JCS at scene may not differ significantly from JCS at emergency department presentation, earlier triage is known to improve outcomes across the trauma literature.
> We really appreciate your valuable comments, which helped considerably improve our manuscript. We have implemented suggested changes; please see additions in RED in the manuscript.
We look forward to hearing from you regarding our submission.
I offer the following suggestions:
1) Discussion of potential pitfalls of assessment using the JCS. While it evaluates eye opening, it relies on understanding of the pathological processes that may affect eye opening spontaneously, to voice, and to central pain. Lack of response to central noxious stim usually implies a severe central process depressing consciousness, but this is not always recognized nor assessed appropriately. Unconsciousness can also be due to systemic insults, electrolyte abnormalities, intoxication, baseline psychiatric comorbidities, and others. As the GCS can be incorrectly administered or scored (e.g. in the setting of intoxication or a sleeping patient), the JCS likely has the same caveats and nuances of administration. This is an relevant point in the context of the important findings of this paper, and would improve the applicability of these findings to the clinical audience.
> Thank you for your important comment. We added the pitfalls you mentioned in the Discussion part as below.
"While JCS has some advantages, it also has some limitations. As the other coma scale such as GCS might be incorrectly scored in some patients (e.g. in the setting of intoxication) 20 , the JCS likely has the same caveats of measurement. In addition, although our study indicated that the JCS level 3 was associated the severe head injury, it is not equivalent with a diagnosis of severe head injury. Unconsciousness can occur due to systemic insults, electrolyte abnormalities, intoxication, baseline psychiatric comorbidities, and other causes."
2) The JCS has increased tiers of scoring with up to 9 tiers of scoring (not including the "alert")
Are there plans to analyze the prognostic and diagnostic ability of more granular tiers of JCS?
> Thank you for your comment. We did not plan to analyse the nine tiers of scoring.
We believe that the most important advantage of JCS is its simplicity. JCS including nine tiers of scoring becomes as complicated as is GCS, without improving its utility as a field triage.
3) Mortality from trauma can be due to a wide range of pathologies, primary and secondary injuries. Recommend authors discuss this in setting of using JCS uniformly across all trauma indications in the manuscript.
>> Thank you for your opinion. We discussed it in the Limitations part as below. > > Thank you for your constructive criticism. We agree with your comment that the AIS and ISS are not very specific for severe head injury and polytrauma, respectively. We didn't plan the additional analysis, and we have now commented on this in the Discussion part as below.
"Moreover, in our study, the c-statistics for the Head AIS ≥3, and ISS ≥16 were lower than that of in-hospital mortality; thus, JCS might not be a suitable instrument to discriminate the anatomical severity of the injury. One possible explanation was that Head AIS ≥3, and ISS ≥16 represent only anatomical severity in trauma. As these items do not include physiological aspects, many patients without disturbance of consciousness might have been included in Head AIS ≥3, and ISS ≥16.
For example, although skull base fracture is coded as Head AIS:3 it might not affect patients' consciousness or prognosis. Therefore, for the JCS to be clinically useful, we should understand the pathological process that may affect the eye-opening." > Thank you for your recommendation. We fundamentally agree with your idea, but other reviewer recommended the clear statement about study flow to sensitivity analysis. Thus, we inserted the information about the sensitivity analysis as below.
7) I apologize if I missed this in the manuscript, but how were the alert patients evaluated? e.g.
JCS=0
> Thank you for your comment. We mentioned that in Methods part as below; "alert patients scored the JCS "0" in the JTDB were combined with JCS Level 1 patients." 8) Minor point: remove "finally" in Abstract (results section, first sentence).
> We deleted it.
We would like to thank you again for your critical appraisal and kind advice.
We believe that your comments have helped make the manuscript better for the readers.
Reviewer: 2 Thank you for the opportunity to review this article investigating the performance of Japan Coma Scale from the Japan Trauma Data Bank. 164,723 patients were included in this study, and the overall mortality was 10.9%. The authors reported a strong association of higher JCS level with in-hospital mortality and the c-statistics of 0.845, and concluded that JCS is useful for field triage of trauma victims. The study objective and the analysis are explicit and well conducted. However, the result needs to be presented more clearly, along with a more detailed discussion of the findings.
>We appreciate your valuable advice, which helped us considerably improve our manuscript. We have implemented suggested changes; please see BLUE in the manuscript.
-A recent systematic review on tGCS, mGCS and Simplified Motor Scale (see  later  comments  regarding  Table  2 ).
> Thank you for your constructive criticism.
We added more information about the clinical management in the Table 3 such as time to hospital arrival, tracheal intubation, neurosurgical intervention, or CT scan. Moreover, based on your advice, we also expanded the Discussion part to include the ways in which the JCS results may affect the clinical management of these patients as below.
"If the patients were assessed as JCS level 3, the protocol recommend to transport the patients to the tertiary critical care center 16 ."
>While we agree with the suggested approach, following discussions within our study team, we recognized that these interventions rely on clinical judgment of physicians and sometimes insistence from family members; as such, they are not objective factors and thus they did not meet our criteria for an outcome.
Introduction/ methods
-It is currently difficult to understand the meaning of level 0 in JCS:
P3 line 41: Additionally, although the originally published JCS did not include a state of alertness, this has been described conventionally as "Level 0" and is generally reported together with Level 1.
P5 line 14: As noted in the Introduction, alertness was recorded as a JCS score of "0" in the JTDB; these patients were combined with JCS Level 1 patients >We apologized for our unclear statement. We have now clarified this in the Methods part as below.
"When JCS published in 1974, the state of "completely awake and alert" was not included in the JCS. In a strict sense, the JCS Level 1 originally indicated spontaneous eye-opening, but not completely awake and alert. However, in recent decades, completely awake and alert patients have been described conventionally as "Level 0" and been treated generally within Level 1.
Thus, in our study the JCS "0" in the JTDB, and it were combined with JCS Level 1 patients."
-the exclusion criteria of missing data and the inclusion of this group for sensitivity analysis is confusing > We apologized for our unclear statement. We revised it for clarity. We added the sensitivity analysis in the study flow chart as below.
P4 line 55: Moreover, we also excluded patients for whom information about the JCS in prehospital settings and in-hospital mortality were unavailable.
P6 line 3: Additionally, we performed a sensitivity analysis to demonstrate the robustness of the primary outcome results and compensate for the risk of selection bias due to the missing JCS and mortality data.
> Thank you for your comment. We revised it in line with this comment.
Results:
-Missing data (excluded from main analysis) comprised of 17% of all eligible patients (from Figure 1) , what was the percentage of missing data for secondary outcomes?
> Thank you for your comment. The number of missing of GCS on arrival, Head AIS and ISS were 9,910 (6.0 %) and 3,517(2.1%) and 3,857 (2.3%), respectively. It added in the table 3.
-This sentence needs to be rewritten with numbers provided. 4.8-5.2) and 13.4 (95% CI: 12.9-13.9)], and severe multiple trauma (ISS ≥16) [Adjusted ORs:
3.0 (95% CI: 2.9-3.1) and 8.9 (95% CI: 8.6-9.3)], respectively (Table 4 )." > Thank you for your comment. We described other parameters in the manuscript.
"The adjusted ORs of the other parameters (Injury type, age, sex, SBP, RR) were described in another part (Supplementary file)."
-Again for sensitivity analysis, summary of results should be provided in the manuscript. So that readers do not need to go to the supplementary files to know the results.
> Thank you for your comment. We added the part of the results of sensitivity analysis in the manuscript as below.
"In assumption 1, adjusted ORs of the JCS levels were as below; 2.7 (95% CI: 2.6-2.9) and 14.0 (95% CI: 13.5-14.5) for Levels 2 and 3, respectively, relative to Level 1."
However, we didn't mention all of the results as that information is presented elsewhere, because we were afraid that the description of all results would be redundant for readers, and the number of word would exceed the limit. If you strongly recommend we present these results, we will revise the manuscript accordingly. Tables   -Table 2 : Sex, age, type of injury, RR, SBP was provided. The descriptive statistics of the primary and secondary outcomes should be included.
-Other information like the intubation rates, neurosurgical intervention rates, ICU admission, hospital length of stay and the prehospital transportation time will help the readers to better understand the trauma study participants in japan. What proportion of patients would have a CT scan?
> Thank you for your comment. We added the variables you mentioned above in the Table 3 . We would like to thank you again for your critical appraisal and kind advice.
We believe that your comments made the manuscript better for the readers.
Reviewer: 3
Reviewer Name: Martin Gerdin Wärnberg Institution and Country: Karolinska Institutet, Sweden
Please state any competing interests or state 'None declared': None declared Please leave your comments for the authors below Thank you for giving me the opportunity to review this work. I found it very interesting and this was the first time I came across the JCS. Now, my recommendation is major revision.
>We really appreciate your valuable advice, which helped us considerably improve our manuscript. We have implemented the suggested changes; please see GREEN in the manuscript.
My most important comments are:
1. The alignment between your aim and methods, results and discussion is not clear. You state that your aim is "to identify the association between the use of JCS at the scene with in-hospital mortality, as well as the usefulness of this scale for outcome prognosis".
First, I do not think that you are studying the association between the use of JCS and mortality.
To me, that implies that you would compare two groups, one in which JCS was used and one in which it wasn't. You would then assess how the use of JCS was associated with mortality. I think a more appropriate way to phrase this part of the aim considering your methods would be "to identify how JCS recorded at the scene is associated with...".
>Thank you for your important opinion. We agree with your idea, and revised the aim as below.
"Therefore, our study aim was to identify the association between the pre-hospital JCS levels with in-hospital mortality and the discrimination ability of pre-hospital JCS for the in-hospital mortality among trauma patients."
Second, I don't think that you can claim to study usefulness by only looking at strength of association and discrimination as performance metrics. I suggest you remove this line from the aim or replace it with "and to assess the discrimination of JCS" or something similar. If you truly want to study usefulness you might want to look into decision curve analysis and net benefit or reclassification measures, which are more clinically relevant.
>Thank you for your comment. As we only focused on the discrimination ability, we have revised the aims of the study accordingly.
2. Make sure that the edits you make in response to 1. are reflected in your discussion and conclusion. For example, I don't think that your study allows you to conclude that "This simple scale would be useful in field triage for trauma victims."
>Thank you for your important opinion. We have deleted the part of the conclusion you mentioned above.
3. There is no mentioning of any ethical considerations. In my opinion this has to be added, including reference to the ethical approval. If this was not applied for a thorough explanation for why this was not done has to be provided.
>Thank you for your important opinion. We described ethical consideration in the "study design and settings" in the method paragraph as below, highlighted in yellow.
"The ethics committee of each institution approved participation in the JTDB; they also approved retrospective analyses using anonymized data from the JTDB."
4. Your statement "We did not estimate a required sample size because our cohort was sufficiently large to enable a regression analysis according to the number of covariates" does not make much sense to me. To be able to say that your cohort is "sufficiently large" you would have to have some idea of what sample size your analysis might require. And if you have an idea, why don't you simply say so and include a reference to whatever work makes you believe that your sample size is enough?
＞Thank you for your comment.
We apologize for an unclear statement.
In terms of sample size estimation, the STROBE statement described as below; "If an analysis is performed on data that were already available for other purposes, the main question is whether the analysis of the data will produce results with sufficient statistical precision to contribute substantially to the literature, and sample size considerations will be informal."
Our study qualified as secondary use of the already available data, thus sample size consideration was informal. However, for using logistic regression analysis, the number of covariates per events is important in consideration of the precision of the estimate.
Generally, the rule of ten events per variable is suggested in the sample size calculation of the logistic regression analysis, (J Clin Epidemiol Vol. 49, No. 12, pp. 1373 -1379 , 1996 , and we discussed about this issue with a bio-statistician (Associate Professor Masaaki Doi, Department of biostatistics, graduate school of Public Health, Kyoto University). We believe our study meets relevant criteria and have thus decided to adopt the rule. Accordingly, our cohort was sufficiently large to enable a regression analysis according to the number of covariates. We have revised the relevant sentence to improve clarity.
"We did not estimate a sample size because our analysis was secondary usage on already available data. Moreover, our cohort had sufficient number of events to enable a regression analysis according to the number of covariates, based on the rule of ten events per variable 15 ."
5. As you rightly point out almost any effect would turn out significant at the 0.05 level considering your large sample size. I therefore suggest that you drop the p-values altogether and focus on interpreting the effect sizes with associated confidence intervals.
> Thank you for your important suggestion. Please see our response to the previous comment where we have addressed considerations of sample size and small differences being detected as statistically significant.
Regarding p-values, we discussed with a bio-statistician (Associate Professor Masaaki Doi, Department of biostatistics, graduate school of Public Health, Kyoto University), and decided against changing the p-value. Analysis of a large sample size can identify small differences, even differences too small to be meaningful in clinical settings. However, in our study, the JCS estimate had an adequately narrow confidence interval, and the effect sizes were sufficiently large to consider them likely to be meaningful in clinical settings. Therefore, we believe it was not necessary to set the p-value lower.
However, as our statement on this issue in Limitations sections might lead to misunderstanding for readers, we have deleted it.
6. Add confidence intervals to the discrimination estimates.
> Thank you for your important suggestion. We added 95%CI of the c statistics (marked in yellow).
7. Your paper needs to be proofread for language, including spelling, grammar and clarity.
> Thank you for your important suggestion. We apologize for language errors. We hope these errors have now been addressed.
association between the pre-hospital JCS levels with inhospital mortality and the discrimination ability of pre-hospital JCS for the in-hospital mortality among trauma patients" in the background. 3. I suspect that the aim in the abstract is better aligned with your analysis, as you have more than one outcome. 4. I suggest you move "The dataset 2018 was derived from 235 hospitals throughout Japan, from January 2004 to December 2017" to right after "We aimed to conduct a cohort study and retrospective analysis for which available all available data were obtained from the Japan Trauma Data Bank (JTDB) dataset 2018." I also suggest that you move "The data were registered by data administrators using inhospital charts and prehospital records submitted by paramedics to the hospitals" to right after "This registry was developed to improve the quality of trauma care by collecting pre-hospital information, clinical information during hospital stays, trauma diagnoses according to the Abbreviated Injury Scale (AIS), Injury Severity Scores (ISS), and mortality outcome". 4. Although I agree that sample size considerations are informal, I still think that you should reflect a bit more on your sample size. You now state that "our cohort had sufficient number of events to enable a regression analysis according to the number of covariates, based on the rule of ten events per variable". First, you would have been "able" to perform the same analysis with a smaller number of events per variable, but with lower precision. So, I recommend that you provide some more reasoning about the number of parameters in your models, how many events they would then require, and why you think that you have "enough". >>We really appreciate your valuable advice, which helped us considerably improve our manuscript.
1. There are still some awkward sentences, for example the new aim: "to identify the association between the pre-hospital JCS levels with in-hospital mortality and the discrimination ability of prehospital JCS for the in-hospital mortality among trauma patients".
2. Please make sure that your aim is expressed in the same way wherever it occurs. For example, the aim in the abstract is "to identify the association between the JCS levels at the scene with inhospital mortality, as well as the discrimination ability for the outcomes" whereas it is "to identify the association between the pre-hospital JCS levels with in-hospital mortality and the discrimination ability of pre-hospital JCS for the in-hospital mortality among trauma patients" in the background.
3. I suspect that the aim in the abstract is better aligned with your analysis, as you have more than one outcome.
123> >Thank you for your advice. We changed the aim to the same one described in the abstract as below.
Therefore, our study aim was to identify the association between the pre-hospital JCS levels with in-hospital mortality and the discrimination ability of pre-hospital JCS for the in-hospital mortality among trauma patients. We aimed to identify the association between the JCS levels at the scene with in-hospital mortality, as well as the discrimination ability for the outcomes.
4. I suggest you move "The dataset 2018 was derived from 235 hospitals throughout Japan, from January 2004 to December 2017" to right after "We aimed to conduct a cohort study and retrospective analysis for which available all available data were obtained from the Japan Trauma Data Bank (JTDB) dataset 2018."
I also suggest that you move "The data were registered by data administrators using in-hospital charts and prehospital records submitted by paramedics to the hospitals" to right after "This registry was developed to improve the quality of trauma care by collecting pre-hospital information, clinical information during hospital stays, trauma diagnoses according to the Abbreviated Injury Scale (AIS), Injury Severity Scores (ISS), and mortality outcome".
4> > Thank you for your advice. We have implemented the suggested changes; please see RED in the manuscript.
4. Although I agree that sample size considerations are informal, I still think that you should reflect a bit more on your sample size. You now state that "our cohort had sufficient number of events to enable a regression analysis according to the number of covariates, based on the rule of ten events per variable". First, you would have been "able" to perform the same analysis with a smaller number of events per variable, but with lower precision. So, I recommend that you provide some more reasoning about the number of parameters in your models, how many events they would then require, and why you think that you have "enough".
4> > Thank you for your advice. We agreed with your advice and changed the statement as you suggested as below.
"We did not calculate a precise sample size because our analysis was secondary usage of already available data. However, based on the rule of ten events per variable, we needed to include 160-200 events at least to be able to adjust the covariates designated in our analysis.15 The prevalence of the events (in-hospital mortality) was estimated at 10% according to the previous studies.10 11 From this, we expected 1600-2000 cases to be a large enough sample size to calculate the point estimates with confidence intervals sufficiently narrow to answer the research question."
5. You state that "all statistical results were considered significant at a two-sided P-value of <0.05" but you do not report any p-values. I would recommend to either remove this line or make sure that you report the p-values of any tests that you might have run.
